explore -WSS

explore

author：focus 2025-09-29 22:51:03 - browse：1665

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： BIO selects John Crowley as new CEO

leisure time

explore

WSS

Pediatric cancer treatments threatened by a new FDA policy

ReNAgade cuts staff seven months after raising $300 million

Walmart eyes Medicare Advantage provider ChenMed

A common UTI test for kids haunts adults as a traumatic 'nightmare'

How medical schools plan to diversify without affirmative action

ReNAgade cuts staff seven months after raising $300 million

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

At least 13 dead in Texas as scorching temps continue

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Cancer drug shortages should be causing more outrage

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

DIEP, the 'gold standard' of breast reconstruction, is under threat

Despite FDA concern, risk that CAR

Walensky prepares to leave CDC — and Congress — behind

WATCH: Why do bright lights make us see spots?

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

leisure time

J&J to emphasize cancer drugs, stop much of its vaccine research

Will the IRA bring competition to the biologics market?

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

A common UTI test for kids haunts adults as a traumatic 'nightmare'

What to do when lifesaving products contribute to climate change

Flagship Pioneering launches a new biotech in two countries

leisure time

explore

Wikipedia

focus